Accent Capital Management’s AngioDynamics ANGO Stock Holding History

Accent Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-260	Closed	-$3.34K	–	339
2025 Q4	$3.34K	Buy	+260	New	+$3.21K	﹤0.01%	327

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Accent Capital Management's ANGO Position: Q1 2026 in Review

Accent Capital Management sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 260 shares — an estimated $3.34K sold.

Accent Capital Management first reported a position in ANGO in Q4 2025 and held it in 1 quarter. The position peaked at $3.34K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Accent Capital Management reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
Accent Capital Management sold 260 AngioDynamics shares in Q1 2026, an estimated $3.34K.
Accent Capital Management first reported a position in AngioDynamics in Q4 2025 and held it in 1 quarter.
Accent Capital Management's AngioDynamics position peaked at $3.34K in Q4 2025.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.